Advertisement

Pediatric Nephrology

, Volume 22, Issue 12, pp 2041–2046 | Cite as

Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE)

  • Sangeeta D. Sule
  • Jeffrey J. Fadrowski
  • Barbara A. Fivush
  • Gregory Gorman
  • Susan L. Furth
Original Article

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects between five and ten thousand children in the USA. Kidney disease may progress to end-stage renal disease (ESRD) and subsequent need for dialysis therapy in a significant number of children with SLE. We performed a cross-sectional analysis comparing achievement of National Kidney Foundation/Kidney Disease Outcomes Quality Initiative clinical targets in pediatric patients with SLE maintained on hemodialysis (HD) to pediatric patients with other causes of ESRD. Ninety-seven unique SLE patients and two control groups—1,823 unique pediatric patients with other causes of ESRD and 694 pediatric patients with glomerulonephritis—were identified in the End Stage Renal Disease Clinical Performance Measures 2000–2004 Project Years. SLE patients were older, with a female and black race predominance compared with both control groups. Pediatric patients maintained on HD secondary to SLE were less likely to meet albumin targets and more likely to have vascular catheters than were pediatric patients on HD secondary to other causes. These findings may be associated with increased morbidity and mortality in pediatric patients with SLE maintained on HD and deserve further study.

Keywords

Systemic lupus erythematosus Pediatrics Dialysis Albumin Vascular access 

References

  1. 1.
    Symmons DP, Jones M, Osborne J, Sills J, Southwood TR, Woo P (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:1975–1980PubMedGoogle Scholar
  2. 2.
    Huemer C, Huemer M, Dorner T, Falger J, Schacherl H, Bernecker M, Artacker G, Pilz I (2001) Incidence of pediatric rheumatic diseases in a regional population in Austria. J Rheumatol 28:2116–2119PubMedGoogle Scholar
  3. 3.
    Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, Huizinga TW (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226PubMedCrossRefGoogle Scholar
  4. 4.
    Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Ognjanovic M, Minic A, Stajic N (2004) Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 19:36–44PubMedCrossRefGoogle Scholar
  5. 5.
    Stichweh D, Arce E, Pascual V (2004) Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16:577–587PubMedCrossRefGoogle Scholar
  6. 6.
    Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M, International Society of Nephrology Working Group on the Classification of Lupus Nephritis, Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530PubMedCrossRefGoogle Scholar
  7. 7.
    Elliot V, Cairns T, Cook HT (2006) Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. Am J Kidney Dis 47:184–190PubMedCrossRefGoogle Scholar
  8. 8.
    Markowitz GS, D’Agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491–495PubMedCrossRefGoogle Scholar
  9. 9.
    Nathanson S, Salomon R, Ranchin B, Macher MA, Lavocat MP, Krier MJ, Baudouin V, Azema C, Bader-Meunier B, Deschenes G (2006) Prognosis of lupus membranous nephropathy in children. Pediatr Nephrol 21:1113–1116PubMedCrossRefGoogle Scholar
  10. 10.
    Marini R, Costallat LT (1999) Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 66:303–309PubMedGoogle Scholar
  11. 11.
    Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444PubMedCrossRefGoogle Scholar
  12. 12.
    Lacks S, White P (1990) Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 17:941–945PubMedGoogle Scholar
  13. 13.
    Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49:501–507PubMedCrossRefGoogle Scholar
  14. 14.
    National kidney foundation (1997) NFK-DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 30:S15–S66Google Scholar
  15. 15.
    National Kidney Foundation (2006) Clinical practice recommendation 8: vascular access in pediatric patients. Am J Kidney Dis 48(Suppl 1):S274–S276Google Scholar
  16. 16.
    KDOQI, National Kidney Foundation (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S11–S145CrossRefGoogle Scholar
  17. 17.
    Hemodialysis Adequacy 2006 Work Group (2006) Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48:S2–S90CrossRefGoogle Scholar
  18. 18.
    K/DOQI, National Kidney Foundation (2000) Clincial practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:S18–S21Google Scholar
  19. 19.
    Rocco MV, Frankenfield DL, Hopson SD, McClellan WM (2006) Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145:512–519PubMedGoogle Scholar
  20. 20.
    Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL (2003) Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol 18:1172–1176PubMedCrossRefGoogle Scholar
  21. 21.
    Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC (2005) Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 20:2797–2802PubMedCrossRefGoogle Scholar
  22. 22.
    Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, Godeau P, Piette JC (1999) Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 78:148–166CrossRefGoogle Scholar
  23. 23.
    Altieri P, Sau G, Cao R, Barracca A, Menneas A, Micchittu B, Cabiddu G, Esposito P, Pani A (2002) Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant 17(Suppl 8):2–9PubMedCrossRefGoogle Scholar
  24. 24.
    Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251–1263PubMedGoogle Scholar
  25. 25.
    Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350PubMedGoogle Scholar
  26. 26.
    Kaysen GA, Stevenson FT, Depner TA (1997) Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658–668PubMedGoogle Scholar
  27. 27.
    Mitch WE, Price SR (2001) Mechanisms activated by kidney disease and the loss of muscle mass. Am J Kidney Dis 38:1337–1342PubMedGoogle Scholar
  28. 28.
    Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P (1995) Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis 26:209–219PubMedGoogle Scholar
  29. 29.
    Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, Shiohira Y, Fukiyama K (1996) Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 28:541–548PubMedGoogle Scholar
  30. 30.
    Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728–736PubMedGoogle Scholar
  31. 31.
    Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB (2004) Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 44:39–46PubMedCrossRefGoogle Scholar
  32. 32.
    Bartosh SM, Fine RN, Sullivan EK (2001) Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 72:973–978PubMedCrossRefGoogle Scholar
  33. 33.
    Fadrowski JJ, Hwang W, Frankenfield DL, Fivush BA (2006) Clinical course associated with vascular access type in a national cohort of adolescents who receive hemodialysis: findings from the clinical performance measures and US renal data system projects. Clin J Am Soc Nephrol 987–992Google Scholar
  34. 34.
    Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C (2002) Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611–622PubMedCrossRefGoogle Scholar
  35. 35.
    Nossent HC, Swaak TJ, Berden JH (1990) Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis: Dutch Working Party on SLE. Am J Med 89:169–174PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2007

Authors and Affiliations

  • Sangeeta D. Sule
    • 1
    • 3
  • Jeffrey J. Fadrowski
    • 1
  • Barbara A. Fivush
    • 1
  • Gregory Gorman
    • 2
  • Susan L. Furth
    • 1
  1. 1.Johns Hopkins University, School of MedicineBaltimoreUSA
  2. 2.National Naval Medical CenterWalter Reed Army Medical CenterBethesdaUSA
  3. 3.BaltimoreUSA

Personalised recommendations